New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

BACKGROUND Growth differentiation factor 15 (GDF-15) is expressed and secreted in
response to inflammation, oxidative stress, hypoxia, telomere erosion, and oncogene …

Red blood cell distribution width (RDW), an integral parameter of the complete blood count
(CBC), has been traditionally used for the classification of several types of anemia. However …

Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular
congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor …

Dietary guidance for patients with heart failure (HF) has traditionally focused on sodium and
fluid intake restriction, but dietary quality is frequently poor in patients with HF and may …

This review provides a comprehensive overview of the past 25+ years of research into the
development of left ventricular assist device (LVAD) to improve clinical outcomes in patients …

Abstract Treatment with the intraaortic balloon pump (IABP) is the most common form of
mechanical support for the failing heart. Augmentation of diastolic pressure during balloon …

Background: Heart failure (HF) is characterized by perturbations in energy homeostasis and
metabolism. The reversibility and prognostic value of circulating markers associated with …

Cardiac remodelling refers to changes in left ventricular structure and function over time,
with a progressive deterioration that may lead to heart failure (HF) development (adverse …

Background Early right-sided heart failure (RHF) after left ventricular assist device (LVAD)
implantation is associated with increased mortality, but little is known about patients who …